Friday, December 22, 2023 11:18:28 AM
As of Dec-22-202311:12:41 AM ET
https://stockcharts.com/h-sc/ui?s=ALXO
See if I might catch a few % of this drift up.
Good Phase 2 Interim Results
Upgrade
Short squeeze
Significant add by stakeholder
Recent ALXO News
- ALX Oncology Announces November Investor Conference Participation • GlobeNewswire Inc. • 11/04/2024 01:00:00 PM
- ALX Oncology Announces Results from Phase 1b/2 Trial of Evorpacept in Combination with Zanidatamab will be Presented at the San Antonio Breast Cancer Symposium (SABCS) 2024 • GlobeNewswire Inc. • 11/01/2024 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2024 01:00:07 PM
- ALX Oncology to Present at the 2024 Cantor Fitzgerald Global Healthcare Conference • GlobeNewswire Inc. • 09/09/2024 12:00:00 PM
- ALX Oncology Announces First Patients Dosed with Evorpacept and Sarclisa As Part of Randomized Phase 1/2 UMBRELLA Study with Sanofi • GlobeNewswire Inc. • 09/04/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 09:10:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 09:09:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 09:06:49 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 08:03:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:08:01 PM
- ALX Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/08/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 09:23:49 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 09:22:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:45:02 PM
- ALX Oncology Appoints Alan Sandler, M.D., to Board of Directors • GlobeNewswire Inc. • 08/06/2024 08:01:00 PM
- ALX Oncology Reports Topline Data From ASPEN-06 Phase 2 Trial Demonstrating Evorpacept Improves Tumor Response in Patients With HER2-Positive Gastric Cancer • GlobeNewswire Inc. • 07/31/2024 08:01:00 PM
- ALX Oncology to Host Investor Call and Webcast to Share Topline Data Results From ASPEN-06 Phase 2 Clinical Trial of Evorpacept for the Treatment of Advanced HER2-Positive Gastric Cancer • GlobeNewswire Inc. • 07/31/2024 09:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 08:06:25 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/11/2024 08:23:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/09/2024 08:09:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 08:21:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 08:06:22 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/04/2024 08:14:18 PM
- ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1 ASPEN-07 Clinical Trial in Patients with Advanced Bladder Cancer • GlobeNewswire Inc. • 06/02/2024 02:00:00 PM
- ALX Oncology Announces Participation in the Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/29/2024 01:00:00 PM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM